AvT PHARMA: what changed
AvT PHARMA
Largest movements
- Cash -€8,178
down €8,178 (-24.3%), from €33,692 to €25,514
mainly Debts after one year (-€131,811) and Other debts (-€6,997)
- Debts after one year -€131,811
down €131,811 (-33.6%), from €392,057 to €260,246
- Current portion of long-term debt +€76,095
up €76,095 (+248%), from €30,716 to €106,811
- Reserves +€48,207
up €48,207 (+135%), from €35,812 to €84,018
- Tax, wage and social debts +€12,366
up €12,366 (+165%), from €7,504 to €19,870
- Other debts -€6,997
down €6,997 (-4.2%), from €166,444 to €159,447
- Gross operating margin +€17,383
up €17,383 (+24.6%), from €70,639 to €88,022
- Taxes +€5,853
up €5,853 (+34.3%), from €17,056 to €22,909
- Financial charges -€888
down €888 (-5.7%), from €15,654 to €14,766
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €686,651 | €681,930 | -€4,721 | -0.7% |
| Fixed assets | 21/28 | €650,504 | €650,504 | = | 0.0% |
| Financial fixed assets | 28 | €650,504 | €650,504 | = | 0.0% |
| Current assets | 29/58 | €36,147 | €31,426 | -€4,721 | -13.1% |
| Amounts receivable within one year | 40/41 | €2,454 | €5,912 | +€3,458 | +141% |
| Trade receivables | 40 | €510 | €0 | -€510 | -100% |
| Other amounts receivable | 41 | €1,944 | €5,912 | +€3,968 | +204% |
| Cash at bank and in hand | 54/58 | €33,692 | €25,514 | -€8,178 | -24.3% |
| Total equity and liabilities | 10/49 | €686,651 | €681,930 | -€4,721 | -0.7% |
| Equity | 10/15 | €85,812 | €134,018 | +€48,207 | +56.2% |
| Contributions | 10/11 | €50,000 | €50,000 | = | 0.0% |
| Reserves | 13 | €35,812 | €84,018 | +€48,207 | +135% |
| Distributable reserves | 133 | €35,812 | €84,018 | +€48,207 | +135% |
| Amounts payable | 17/49 | €600,839 | €547,912 | -€52,927 | -8.8% |
| Amounts payable after more than one year | 17 | €392,057 | €260,246 | -€131,811 | -33.6% |
| Financial debts | 170/4 | €392,057 | €260,246 | -€131,811 | -33.6% |
| Amounts payable within one year | 42/48 | €208,602 | €287,666 | +€79,064 | +37.9% |
| Current portion of amounts payable after more than one year | 42 | €30,716 | €106,811 | +€76,095 | +248% |
| Trade debts | 44 | €3,938 | €1,537 | -€2,400 | -61.0% |
| Suppliers | 440/4 | €3,938 | €1,537 | -€2,400 | -61.0% |
| Taxes, remuneration and social security | 45 | €7,504 | €19,870 | +€12,366 | +165% |
| Taxes | 450/3 | €7,504 | €19,870 | +€12,366 | +165% |
| Other amounts payable | 47/48 | €166,444 | €159,447 | -€6,997 | -4.2% |
| Accrued charges and deferred income | 492/3 | €180 | €0 | -€180 | -100% |
| Remuneration, social security and pensions | 62 | €1,680 | €1,741 | +€61 | +3.7% |
| Other operating charges | 640/8 | €437 | €400 | -€38 | -8.6% |
| Gross operating margin | 9900 | €70,639 | €88,022 | +€17,383 | +24.6% |
| Operating profit (loss) | 9901 | €68,522 | €85,881 | +€17,360 | +25.3% |
| Financial charges | 65/66B | €15,654 | €14,766 | -€888 | -5.7% |
| Recurring financial charges | 65 | €15,654 | €14,766 | -€888 | -5.7% |
| Profit (loss) for the period before taxes | 9903 | €52,867 | €71,115 | +€18,248 | +34.5% |
| Income taxes | 67/77 | €17,056 | €22,909 | +€5,853 | +34.3% |
| Profit (loss) for the period | 9904 | €35,812 | €48,207 | +€12,395 | +34.6% |
| Profit (loss) for the period to be appropriated | 9905 | €35,812 | €48,207 | +€12,395 | +34.6% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.